Cargando…

Psoriatic Skin Lesions after Apalutamide Treatment

Detalles Bibliográficos
Autores principales:	MIYAGAWA, Fumi, AKIOKA, Nobuya, YOSHIDA, Noriko, OGAWA, Kohei, ASADA, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631272/ https://www.ncbi.nlm.nih.gov/pubmed/35191508 http://dx.doi.org/10.2340/actadv.v102.858

Ejemplares similares

Erythema Multiforme Major in Angioimmunoblastic T-cell Lymphoma
por: HATTORI, Shoko, et al.
Publicado: (2021)

Adult-onset Asymmetrical Lipomatosis
por: AOKI, Yuki, et al.
Publicado: (2020)

Correlation Between Expression of CD134, a Human Herpesvirus 6 Cellular Receptor, on CD4(+) T cells and Th2-type Immune Responses in Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
por: MIYAGAWA, Fumi, et al.
Publicado: (2020)

Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
por: OSAWA, Kana, et al.
Publicado: (2022)

A Case of Systemic Lupus Erythematosus with Cutaneous Leukocytoclastic Vasculitis Mimicking Bullous SLE
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Comparison of Cytokine Expression in Paediatric and Adult Psoriatic Skin
por: KIM, Jin Cheol, et al.
Publicado: (2020)

High Expression of Lactate Dehydrogenase A is a Potential Promoter of Malignant Behaviour in Extramammary Paget’s Disease
por: OGAWA, Kohei, et al.
Publicado: (2021)

Hypothyroidism caused by apalutamide
por: Daviduck, Quinn, et al.
Publicado: (2023)

Apalutamide‐associated skin rash in patients with prostate cancer: Histological evaluation by skin biopsy
por: Tohi, Yoichiro, et al.
Publicado: (2021)

Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis
por: CHELLI, Clara, et al.
Publicado: (2020)

Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019)

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

The expression of syndecan-1 in psoriatic epidermis
por: Tomas, Davor, et al.
Publicado: (2008)

Successful Treatment of Diffuse Normolipemic Plane Xanthoma with Probucol
por: Miyagawa, Fumi, et al.
Publicado: (2013)

DNA methylation age is not affected in psoriatic skin tissue
por: Shen, Changbing, et al.
Publicado: (2018)

Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
por: Fujmoto, Saizo, et al.
Publicado: (2022)

Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
por: Gul, Anita, et al.
Publicado: (2019)

Expression of Telomerase Reverse Transcriptase in Psoriatic Lesional Skin
por: Mahmoud, Moushira A., et al.
Publicado: (2006)

Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to date
por: Chong, Julio T, et al.
Publicado: (2018)

Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Characteristics of Patients with Generalized Pustular Psoriasis and Psoriatic Arthritis: A Retrospective Cohort Study
por: MANONE-ZENKE, Yukari, et al.
Publicado: (2022)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
por: SADOGHI, Birgit, et al.
Publicado: (2021)

Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer
por: De Velasco, Marco A., et al.
Publicado: (2021)

Changes in Proteome of Fibroblasts Isolated from Psoriatic Skin Lesions
por: Gęgotek, Agnieszka, et al.
Publicado: (2020)

Anti-Centromere Antibody Positivity in a Patient with Generalized Morphea
por: Miyagawa, Fumi, et al.
Publicado: (2018)

Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis
por: VAN DEN MUNCKHOF, Ellen H. A., et al.
Publicado: (2020)

Pustular Skin Lesions in an Adult Female Patient with X-linked Dominant Chondrodysplasia Punctata with a Novel Emopamil Binding Protein Mutation: A Rare Skin Manifestation
por: HASEGAWA, Akito, et al.
Publicado: (2021)

FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis
por: da Hora, Anadilton Santos, et al.
Publicado: (2020)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer
por: Honda, Tomoko, et al.
Publicado: (2022)

Xanthomatous sialadenitis: Autoimmune- or treatment-induced lesions?
por: Handra-Luca, Adriana
Publicado: (2017)

Attenuation of an adult T-cell leukemia skin lesion after treatment of a concomitant herpes simplex infection: a case study
por: Tomita, Hajime, et al.
Publicado: (2012)

Management of secondary embolization that arose after intraarterial thrombolytic treatment of cosmetic facial filler-induced arterial occlusion
por: Nomoto, Shunichi, et al.
Publicado: (2021)

Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
por: Belasco, Jennifer, et al.
Publicado: (2015)

Psoriatic arthritis with skin lesions localized to the scalp: A case report
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
por: Alkhudair, Nora A.
Publicado: (2019)

The earlier the better? Apalutamide for non-metastatic castration resistant prostate cancer
por: De Santis, Maria, et al.
Publicado: (2019)

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
por: Small, E J, et al.
Publicado: (2019)

Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)
por: Naka, Go, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ou55lv1qvccocc1ia1bvttfbud